Table 1.
Overview of -omic types, sample types, platforms, collection methods, and analyte count for the QMDiab and ROS/MAP datasets
| Dataset | Omic type | Sample type | Platform | Method | # of analytes |
|---|---|---|---|---|---|
|
QMDiab (n = 410) |
Metabolomics | Plasma | Metabolon (HD2) | UHPLC/GC-MS/MS | 466 |
| Plasma | Metabolon (HD4) | UHPLC/GC-MS/MS | 843 | ||
| Plasma | Nightingale | NMR | 224 | ||
| Plasma | Biocrates p150 | FIA-MS/MS | 161 | ||
| Saliva | Metabolon | UHPLC/GC-MS/MS | 251 | ||
| Urine | Metabolon | UHPLC/GC-MS/MS | 695 | ||
| Urine | Chenomx | NMR | 32 | ||
| Proteomics | Plasma | SOMAscan | SOMAmer + DNA microarray | 1141 | |
| Lipidomics | Plasma | Metabolon (Lipidyzer) | LC-MS | 1133 | |
| Glycomics | Plasma | Genos | IgG | 39 | |
| Plasma | Genos | Total N-glycans | 60 | ||
| Plasma | Leiden University | IgA | 90 | ||
|
ROS/MAP (n = 500) |
Metabolomics | Brain Tissue | Metabolon | UHPLC/GC-MS/MS | 667 |
| Proteomics | Brain Tissue | ACQUITY UPLC + TSQ-Vantage MS | UHPLC-MS/MS | 7526 |